As of November 6, 2026, Rezolute, Inc. is a publicly traded company (Nasdaq: RZLT); its largest reported holder is Opaleye Management Inc., with 6.58% on Schedule 13G/A of May 11, 2026, then Dellora Investments LP (5.9%). The largest insider holding is Young-Jin Kim, a director, with 8,594,336 shares (8.9% of shares outstanding), per Form 4 of November 21, 2025 (Schedule 13G/A, May 11, 2026).
Is this your company?
About to sign with, pay or invest in Rezolute, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Rezolute, Inc. a real, registered company?
- Rezolute, Inc. files with the SEC under CIK 1509261 (its SEC filings).
- Its shares are listed under the ticker RZLT on Nasdaq (SEC company record).
- Incorporated in Nevada; business address in Redwood City, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under REZOLUTE INC in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Jennison Associates LLC (filed 2026-10-28).
Who are Rezolute, Inc.'s owners and officers?
Rezolute, Inc.: incorporated in Nevada; business address in Redwood City, California; industry Pharmaceutical Preparations (Schedule 13G, 2026-10-28).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-28 | Jennison Associates LLC | 5.5% |
| Schedule 13G/A, 2026-08-14 | Balyasny Asset Management L.P. | 4.84% |
| Schedule 13G/A, 2026-08-12 | Bank Of America Corp /De/ | 1.2% |
| Schedule 13G, 2026-08-12 | Dellora Investments LP | 5.9% |
| Schedule 13G, 2026-05-15 | Balyasny Asset Management L.P. | 5.28% |
| Schedule 13G/A, 2026-05-11 | Opaleye Management Inc. | 6.58% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-13 | Invus Public Equities, L.P. | 0% |
| Schedule 13G, 2026-02-11 | Bank Of America Corp /De/ | 6.5% |
| Schedule 13G, 2026-01-30 | The Vanguard Group | 5.16% |
| Schedule 13G/A, 2026-01-08 | Fmr LLC | 2.5% |
| Schedule 13G, 2025-12-19 | Opaleye Management Inc. | 5.3% |
Questions about who owns Rezolute, Inc.
Who owns Rezolute, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Rezolute, Inc.: Opaleye Management Inc. (6.58%, Schedule 13G/A, filed 2026-05-11), Dellora Investments LP (5.9%, Schedule 13G, filed 2026-08-12) and Jennison Associates LLC (5.5%, Schedule 13G, filed 2026-10-28).
Who are the largest shareholders of Rezolute, Inc.?
By the share each holder's latest filing reports, the largest holders of Rezolute, Inc. on this page are Opaleye Management Inc. (6.58%), Dellora Investments LP (5.9%) and Jennison Associates LLC (5.5%).
When did Opaleye Management Inc. buy into Rezolute, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Opaleye Management Inc. on this page is the Schedule 13G, filed 2025-12-19, reporting 5.3%; its latest, Schedule 13G/A filed 2026-05-11, reports 6.58%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Rezolute, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Rezolute, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Rezolute, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Rezolute, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 8,594,336 shares (8.9% of shares outstanding), 170,950 held directly and 8,423,386 indirectly (Form 4, 2025-11-21).
- , the chief executive and a director: 605,497 shares (0.63% of shares outstanding) (Form 4, 2026-07-07).
- , the chief financial officer: 477,400 shares (0.49% of shares outstanding), 395,400 held directly and 82,000 indirectly (Form 4, 2026-10-23).
- , the chief medical officer: 309,351 shares (0.32% of shares outstanding), 293,851 held directly and 15,500 indirectly (Form 4, 2026-07-07).
- , a director: 119,675 shares (0.12% of shares outstanding) (Form 4, 2025-12-17).
Shares outstanding: 96,728,913 as of 2026-11-02, from the company's latest SEC cover page.
How much has Rezolute, Inc. raised?
No fundraising or offering filing from Rezolute, Inc. is on file with us.
Keep reading
More on Rezolute, Inc. and the records around it.
Rezolute, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- Dellora Investments Master Fund LP also filed stake reports on 1 other company: TENAX THERAPEUTICS, INC. (Oct 2026)
- Opaleye Management Inc. also filed stake reports on 12 other companies: Codexis, Inc. (Nov 2026), Gossamer Bio, Inc. (Nov 2026), Pasithea Therapeutics Corp. (Nov 2026)
- Jennison Associates LLC also filed stake reports on 14 other companies: LENDINGTREE INC (Oct 2026), PALVELLA THERAPEUTICS INC (Oct 2026), NEUROGENE INC (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/rezolute